Clinical Trial Details
| Trial ID: | L2302 |
| Source ID: | NCT03959865 |
| Associated Drug: | Long-Acting Glp-1ra |
| Title: | GLP-1 REceptor Agonists and Real World EvIdeNce |
| Acronym: | GLP-1REWIN |
| Status: | UNKNOWN |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes |
| Interventions: | DRUG: Long-acting GLP-1RA|DRUG: Short-acting GLP-1RA|DRUG: Human-based GLP-1RA|DRUG: Exendin-based GLP-1RA|DRUG: Fixed ratio BI/GLP-1RA combination|DRUG: Flexible BI/GLP-1RA combination |
| Outcome Measures: | Primary: HbA1c, Change in HbA1c from baseline to end of follow-up, 3-12 months | Secondary: Weight, Change in body weight from baseline to end of follow-up, 3-12 months|Blood pressure, Change in systolic blood pressure from baseline to end of follow-up, 3-12 months|Persistence, Percentage of patients who persist on treatment at the end of follow-up, 3-12 months |
| Sponsor/Collaborators: | Sponsor: University of Padova | Collaborators: Azienda Ospedaliera di Padova |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | |
| Enrollment: | 6000 |
| Study Type: | OBSERVATIONAL |
| Study Designs: | Observational Model: |Time Perspective: p |
| Start Date: | 2018-12-19 |
| Completion Date: | 2019-05-31 |
| Results First Posted: | |
| Last Update Posted: | 2019-05-22 |
| Locations: | Servizio di Diabetologia UOC Medicina Generale, Cittadella, Padova, 35013, Italy|U.O.S Diabetologia, Ospedale di Schiavonia, Monselice, Padova, 35043, Italy|U.O. Diabetologia ULSS2, Pieve di Soligo, Treviso, 31053, Italy|U.O. Diabetologia e Dietetica ULSS6, Padova, 35100, Italy|Azienda Ospedaliera di Padova, Padova, 35128, Italy|Diabetologia ULSS2, Treviso, 31100, Italy |
| URL: | https://clinicaltrials.gov/show/NCT03959865 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|